Bottom line
IYH vs PRHSX: the short answer
IYH (iShares U.S. Healthcare ETF) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 77% by weight.
But PRHSX is far broader, holding 279 positions to 103 for IYH, so beyond the top names it adds exposure IYH doesn't have.
IYH is cheaper at 0.37% vs 0.83% — a difference of $46 a year per $10,000 invested.
Over five years, IYH returned +7.0% a year vs +4.2% for PRHSX.
Updated Nov 19, 2026
IYH vs PRHSX side by side
| IYH | PRHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 0.83% |
| Annual cost per $10k | $37 | $83 |
| 10-yr cost on $10k (prospectus) | $468 | $1,025 |
| Max front load | None | — |
| 12b-1 fee | 0% | — |
| 1-yr return | +13.1% | +17.7% |
| 5-yr return (annualized) | +7.0% | +4.2% |
| 10-yr return (annualized) | +9.4% | +9.1% |
| Best quarter | +15.3% | +23.5% |
| Worst quarter | −12.7% | −15.8% |
| Net assets (fund) | $3.6B | $11.9B |
| Number of holdings | 103 | 279 |
| Portfolio turnover | 3% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IYH | PRHSX | Difference |
|---|---|---|---|
| 2025 | +13.1% | +17.7% | −4.6% |
| 2024 | +3.1% | +1.8% | +1.3% |
| 2023 | +2.1% | +3.1% | −1.0% |
| 2022 | −4.4% | −12.2% | +7.8% |
| 2021 | +23.4% | +13.3% | +10.1% |
| 2020 | +15.5% | +30.1% | −14.6% |
| 2019 | +20.8% | +29.1% | −8.3% |
| 2018 | +5.9% | +1.2% | +4.6% |
| 2017 | +22.3% | +28.0% | −5.6% |
| 2016 | −2.8% | −10.4% | +7.5% |
Source: Fund prospectus bar charts
Holdings overlap
15 of IYH's top 25 holdings also appear in PRHSX's top 25.
| Holding | IYH | PRHSX |
|---|---|---|
| Eli Lilly And Company | 15.11% | 14.28% |
| Johnson & Johnson | 10.17% | 6.63% |
| Abbvie Inc. | 7.32% | 5.10% |
| Unitedhealth Group Incorporated | 6.16% | 5.99% |
| Merck & Co., Inc. | 5.31% | 4.01% |
| Thermo Fisher Scientific Incorporated | 3.52% | 2.52% |
| Amgen Inc. | 3.42% | 1.82% |
| Abbott Laboratories | 3.02% | 1.89% |
| Gilead Sciences, Inc. | 2.66% | 2.82% |
| Bristol-myers Squibb Company | 2.20% | 2.11% |
| Intuitive Surgical, Inc. | 2.05% | 1.87% |
| Danaher Corporation | 2.03% | 1.43% |
| Vertex Pharmaceuticals Incorporated | 2.00% | 2.28% |
| Stryker Corporation | 1.86% | 1.78% |
| Elevance Health, Inc. | 1.34% | 1.53% |
Source: SEC Form N-PORT
IYH top 10
- Eli Lilly And Company — 15.11%
- Johnson & Johnson — 10.17%
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Merck & Co., Inc. — 5.31%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between IYH and PRHSX?
Which is cheaper, IYH or PRHSX?
Should I own both IYH and PRHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.